Increasing bowel cancer screening using SMS in general practice : the SMARTscreen cluster randomised trial
© The Authors..
BACKGROUND: Australia has one of the highest incidences of colorectal cancer (CRC) worldwide. The Australian National Bowel Cancer Screening Program (NBCSP) is a best-practice, organised screening programme, but uptake is low (40.9%) and increasing participation could reduce morbidity and mortality associated with CRC. Endorsement by GPs is strongly associated with increasing screening uptake.
AIM: This study (SMARTscreen) aimed to test whether a multi-intervention short message service (SMS) sent by general practices to 50-60-year-old patients who were due to receive the NBCSP kit would increase NBCSP uptake, by comparing it with usual care.
DESIGN AND SETTING: A stratified cluster randomised controlled trial was undertaken, involving 21 Australian general practices in Western Victoria, Australia.
METHOD: For intervention practices, people due to receive the NBCSP kit within a 6-month study period were sent an SMS just before receiving the kit. The SMS included a personalised message from the person's general practice endorsing the kit, a motivational narrative video, an instructional video, and a link to more information. Control practices continued with usual care, comprising at-home testing with a faecal immunochemical test (FIT) through the NBCSP. The primary outcome was the between-arm percentage difference in uptake of FIT screening within 12 months from randomisation, which was estimated using generalised linear model regression.
RESULTS: In total, 39.2% (1143/2914) of people in 11 intervention practices and 23.0% (583/2537) of people in 10 control practices had a FIT result in their electronic health records - a difference of 16.5% (95% confidence interval = 2.02 to 30.9).
CONCLUSION: The SMS intervention increased NBCSP kit return in 50-60-year-old patients in general practice. This finding informed a larger trial - SMARTERscreen - to test this intervention in a broader Australian population.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:74 |
|---|---|
| Enthalten in: |
The British journal of general practice : the journal of the Royal College of General Practitioners - 74(2024), 741 vom: 27. März, Seite e275-e282 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
McIntosh, Jennifer G [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Bowel cancer screening |
|---|
| Anmerkungen: |
Date Completed 29.03.2024 Date Revised 29.03.2024 published: Electronic-Print Citation Status MEDLINE |
|---|
| doi: |
10.3399/BJGP.2023.0230 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366552260 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366552260 | ||
| 003 | DE-627 | ||
| 005 | 20240330000719.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240108s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3399/BJGP.2023.0230 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1355.xml |
| 035 | |a (DE-627)NLM366552260 | ||
| 035 | |a (NLM)38164588 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a McIntosh, Jennifer G |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Increasing bowel cancer screening using SMS in general practice |b the SMARTscreen cluster randomised trial |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.03.2024 | ||
| 500 | |a Date Revised 29.03.2024 | ||
| 500 | |a published: Electronic-Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © The Authors. | ||
| 520 | |a BACKGROUND: Australia has one of the highest incidences of colorectal cancer (CRC) worldwide. The Australian National Bowel Cancer Screening Program (NBCSP) is a best-practice, organised screening programme, but uptake is low (40.9%) and increasing participation could reduce morbidity and mortality associated with CRC. Endorsement by GPs is strongly associated with increasing screening uptake | ||
| 520 | |a AIM: This study (SMARTscreen) aimed to test whether a multi-intervention short message service (SMS) sent by general practices to 50-60-year-old patients who were due to receive the NBCSP kit would increase NBCSP uptake, by comparing it with usual care | ||
| 520 | |a DESIGN AND SETTING: A stratified cluster randomised controlled trial was undertaken, involving 21 Australian general practices in Western Victoria, Australia | ||
| 520 | |a METHOD: For intervention practices, people due to receive the NBCSP kit within a 6-month study period were sent an SMS just before receiving the kit. The SMS included a personalised message from the person's general practice endorsing the kit, a motivational narrative video, an instructional video, and a link to more information. Control practices continued with usual care, comprising at-home testing with a faecal immunochemical test (FIT) through the NBCSP. The primary outcome was the between-arm percentage difference in uptake of FIT screening within 12 months from randomisation, which was estimated using generalised linear model regression | ||
| 520 | |a RESULTS: In total, 39.2% (1143/2914) of people in 11 intervention practices and 23.0% (583/2537) of people in 10 control practices had a FIT result in their electronic health records - a difference of 16.5% (95% confidence interval = 2.02 to 30.9) | ||
| 520 | |a CONCLUSION: The SMS intervention increased NBCSP kit return in 50-60-year-old patients in general practice. This finding informed a larger trial - SMARTERscreen - to test this intervention in a broader Australian population | ||
| 650 | 4 | |a Randomized Controlled Trial | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a bowel cancer screening | |
| 650 | 4 | |a colorectal cancer | |
| 650 | 4 | |a general practice | |
| 650 | 4 | |a primary health care | |
| 700 | 1 | |a Jenkins, Mark |e verfasserin |4 aut | |
| 700 | 1 | |a Wood, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Chondros, Patty |e verfasserin |4 aut | |
| 700 | 1 | |a Campbell, Tina |e verfasserin |4 aut | |
| 700 | 1 | |a Wenkart, Edweana |e verfasserin |4 aut | |
| 700 | 1 | |a O'Reilly, Clare |e verfasserin |4 aut | |
| 700 | 1 | |a Dixon, Ian |e verfasserin |4 aut | |
| 700 | 1 | |a Toner, Julie |e verfasserin |4 aut | |
| 700 | 1 | |a Martinez-Gutierrez, Javiera |e verfasserin |4 aut | |
| 700 | 1 | |a Govan, Linda |e verfasserin |4 aut | |
| 700 | 1 | |a Emery, Jon D |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The British journal of general practice : the journal of the Royal College of General Practitioners |d 1996 |g 74(2024), 741 vom: 27. März, Seite e275-e282 |w (DE-627)NLM012664286 |x 1478-5242 |7 nnns |
| 773 | 1 | 8 | |g volume:74 |g year:2024 |g number:741 |g day:27 |g month:03 |g pages:e275-e282 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3399/BJGP.2023.0230 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 74 |j 2024 |e 741 |b 27 |c 03 |h e275-e282 | ||